CDC 2026: Immunization Updates: Precision Prevention in Primary Care
-
Register
- User - $40
This continuing education session offers nurse practitioners an update on the 2026 immunization guidelines and relevant clinical practices essential for primary care and preventive health. The presentation will cover recent modifications to the CDC's Advisory Committee on Immunization Practices (ACIP) recommendations, including updates to routine and catch-up immunizations for patients of all ages. Topics include changes in vaccination schedules, current guidance on COVID-19, influenza, RSV, HPV, pneumococcal, meningococcal, and other vaccine-preventable diseases, as well as strategies for integrating shared decision-making into patient consultations. Attendees will also receive communication strategies to address vaccine hesitancy and promote immunization acceptance within diverse patient populations. This session is designed to support evidence-based practice and fulfill continuing education requirements for advanced practice nurses.
*Due to rapidly changing clinical knowledge, once purchased, you have 90 days access to complete this education.
Credits: 1.5 Contact Hours; 1.5 are Pharmacology
This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 5/5/2026 to 5/4/2027 . PAs should only claim credit commensurate with the extent of their participation.
Expiration Date: December 31, 2026
$40
LEARNING OBJECTIVES
After taking part in this educational activity, participants should be better able to:
1. Implement effective patient communication strategies to address vaccine hesitancy, improve immunization confidence, and increase vaccination uptake across diverse patient populations.
2. Interpret and apply the 2026 ACIP/CDC immunization schedule updates for pediatric, adolescent, adult, and special populations in everyday clinical practice.
3. Interpret and apply the 2026 ACIP/CDC immunization schedule updates for pediatric, adolescent, adult, and special populations in everyday clinical practice.
Damien Fisher
PharmD., AE-C
Damien Fisher, PharmD, is a clinical pharmacy specialist with extensive experience in ambulatory care, academia, and biologic therapy management. He earned his Doctor of Pharmacy degree from Florida A&M University College of Pharmacy in 2004. Following graduation, Dr. Fisher completed an ASHP-accredited residency with an emphasis in Community and Ambulatory Care at the University of Tennessee, where he developed a strong foundation in direct patient care, chronic disease management, and interdisciplinary collaboration. Dr. Fisher's professional interests led him into academia, where he has held Clinical Assistant Professor appointments at Hampton University School of Pharmacy, University of Houston College of Pharmacy, and South University School of Pharmacy. He currently serves as an Adjunct Professor at Texas Southern University College of Pharmacy, contributing to the education and mentorship of future pharmacists. In his clinical role, Dr. Fisher is an Outpatient Allergy, Dermatology, and Pulmonology Clinical Pharmacy Specialist with the University of Texas Medical Branch (UTMB) Health League City team. His practice focuses on optimizing complex biologic therapies, patient education, and interdisciplinary care coordination. Additionally, he serves as Director of the Pharmacy Services Access Coordinator Boot Camp, where he educates patients and healthcare providers on biologic access, affordability programs, and navigation of medication assistance pathways.
Outside of his professional roles, Dr. Fisher is an avid movie enthusiast with a passion for cinema.
CE/CME INFORMATION
Obtain Your Credits
To earn credits for this activity, navigate to the Content(s) tab and complete all course components in the following order: 1) watch the course presentation video; 2) complete the course evaluation; 3) pass the post-test with a score of 2/3 (66.7%) or higher. You may retake the post-test until a passing score is achieved, at which point you will be able to view/print a copy of your certificate of completion. This online certificate will also be saved within your profile 'My Courses/Certificates' -> 'Transcript/Certificates Earned' for future access.
Designation Statement
NPACE designates this educational activity for a maximum of 1.5 contact hours, of which 1.5 is pharmacology credit. Participants should claim only credit commensurate with the extent of their participation in the activity.
This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid from 5/5/2026 to 5/4/2027
Accreditation Statement
Nurse Practitioner Associates for Continuing Education is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
DISCLOSURES
Faculty
Contributing faculty, Damien Fisher PharmD., AE-C has disclosed no relevant financial relationship.
Planners
All planners and contributors involved in this educational activity have disclosed no relevant financial relationships.
Disclaimer
The material presented in this continuing education program is being made available for educational purposes only and is not intended to represent the best or only methods, medications and/or guidelines appropriate for the medical situation discussed. Rather the material is intended to present an approach, view, statement, or opinion of the presenter(s), which may be helpful, or of interest to other practitioners and should not be used by clinicians without the evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. NPACE disclaims any liability, loss, injury, or damage incurred as a consequence, directly or indirectly, of the use and application of any information given in a presentation.
Disclosure of Unlabeled Use
This educational activity may mention the uses of products that are not approved by the FDA for the indication(s) being discussed. The presenter(s) are instructed to notify participants when they are discussing unapproved uses or investigational agents. The opinions related to unapproved uses of products are solely those of the presenter(s) and are not endorsed or recommended by NPACE. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.
Commercial Support
There is no commercial support for this activity.
